novartis glp-1 receptor agonist The Impact of Agonists on Ocular Disease GLP-1 Receptor Agonist - RawBiotix

Read More GLP-1 Patches vs Oral GLP-1 Support Based on current evidence, oral GLP-1 support has a much stronger scientific foundation

doi:10.1136/bmj.j2499

GLP-1s are approved for weight loss in adults who have a body mass index of 30 or higher, and those who are overweight with a body mass index of 27 or higher with at least one weight-related health condition such as high blood pressure, high cholesterol and type 2 diabetes

Additionally, it is important to determine how well the new drugs perform in the long run and whether they are safe

We performed metarregression to evaluate if there was a trend towards higher incidence of pancreatic cancer in studies with longer duration, however no association between duration and the outcome was observed